205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.82%
Net income growth under 50% of MRVL's 102.60%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
6.76%
D&A growth well above MRVL's 0.14%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-550.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
6.73%
SBC growth well above MRVL's 10.22%. Michael Burry would flag major dilution risk vs. competitor’s approach.
40.90%
Well above MRVL's 32.22% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-538.89%
AR is negative yoy while MRVL is 28.17%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
16.95%
Inventory shrinking or stable vs. MRVL's 35.37%, indicating lean supply management. David Dodd would confirm no demand shortfall.
159.68%
A yoy AP increase while MRVL is negative at -193.65%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
71.68%
Growth well above MRVL's 137.33%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-177.42%
Negative yoy while MRVL is 6804.38%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
20.60%
Operating cash flow growth below 50% of MRVL's 70.17%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-47.25%
Both yoy lines negative, with MRVL at -95.32%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-34.32%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-23.87%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
1150.00%
We have some outflow growth while MRVL is negative at -200.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-8617.86%
Both yoy lines negative, with MRVL at -57.65%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
64.21%
We repay more while MRVL is negative at -237.61%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-23.53%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
23.30%
We have some buyback growth while MRVL is negative at -233.33%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.